Core Viewpoint - MGBlab is leading a paradigm revolution in global micro-ecological health by reconstructing health interventions through the microbiome, focusing on the gut-brain axis and leveraging proprietary technologies and industry standards [1] Group 1: Research and Innovation - MGBlab positions itself as a "microbial medical innovation engine" by reconstructing the underlying rules of the industry through patented technology and industry standards [2] - The company has developed a high-throughput anaerobic single-cell screening platform that enhances strain selection efficiency by 10,000 times compared to traditional methods [2] - The WisMarker model advances research from correlation to causation in linking gut microbiota with health issues such as developmental disorders and mental health conditions [2] Group 2: Value Standards and Industry Standards - MGBlab has drafted the world's first standard for high-throughput sequencing interpretation of human gut microbiota, filling a gap in China's microbiome detection standardization [3] - The company is the primary drafting unit for the "Probiotic Preparations Food" group standard, establishing technical requirements and quality control systems for probiotic products [3] - The AI-driven Cross-Feeding Probiotics (CFP) platform enhances strain survival and colonization efficiency by over 30% [3] Group 3: Clinical Research and Patents - MGBlab collaborates with prestigious institutions to conduct clinical trials, replacing empirical methods with a three-dimensional evidence chain [4] - The company has secured over 40 patents, reinforcing its research barriers and technological capabilities [5] - The WisMarker model integrates over 500,000 clinical samples and gut metagenomic data, achieving predictive accuracy at an internationally advanced level [6] Group 4: Technological Framework - MGBlab's IMM platform has identified thousands of maternal strains, addressing gut compatibility issues for the Chinese population [7] - The SMART platform provides systematic microbiome assessment and reconstructive therapy, creating a closed-loop system of resources, technology, and application [10] Group 5: Strategic Development - MGBlab's "10-2-1 China Maternal Strain Initiative" aims to localize technology and reduce reliance on foreign strains, which currently dominate 85% of the Chinese infant probiotic market [11] - The initiative is supported by over 2,000 strain selection experiments daily and more than 19 clinical studies annually, demonstrating a commitment to practical advancements [12] - The company's efforts are redefining the global infant micro-ecological intervention landscape through localized strain development [12]

Company Overview - Minsheng Health has a diverse business structure, including vitamin and mineral supplements, probiotics, and medical beauty products [1] - The company has established a full industrial chain in the probiotics sector, enhancing its competitive advantage [2][3] Growth in Core Products - The main product, 21 Jinweita® Multivitamin Tablets, has seen a steady increase in market share [2] - Online sales have expanded significantly through three dedicated online business units, contributing to overall revenue growth [2] Probiotics Market Strategy - The company has developed a comprehensive probiotics ecosystem, including over 6,500 strains in its proprietary "Yanhuang Strain Library" [3] - Focus on functional strains and unique technologies to differentiate products in the probiotics market [3] New Product Launches - Minoxidil solution is set to launch in August 2025, while Varenicline tablets are planned for September 2025 [4] - Different marketing strategies will be employed for each product, with a focus on consumer health education for Varenicline [4] Challenges and Solutions - The decline in foot traffic at offline pharmacies poses a challenge; however, the company has built strong relationships with pharmacies to mitigate this [5] - The new skincare brand, Jisuran, aims to convert low-frequency pharmaceutical purchases into higher-frequency skincare sales [5] Organizational Structure - Each business segment operates independently, with dedicated departments for OTC, online retail, and medical beauty [6] - The company emphasizes talent retention and management efficiency to ensure sustainable growth [6] Long-term Strategic Goals - Maintain steady growth in the core vitamin and mineral supplement business [6] - Position the probiotics segment as a second growth curve to catch up with industry leaders [6]